AI assistant
RAPID MICRO BIOSYSTEMS, INC. — Director's Dealing 2025
Oct 21, 2025
33936_dirs_2025-10-21_20106c91-9da5-48f2-9138-6e0af921c921.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK: 0001380106
Period of Report: 2025-10-17
Reporting Person: Spignesi Robert G. Jr. (Director, PRESIDENT AND CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-17 | Class A Common Stock | M | 3400 | $0.75 | Acquired | 973950 | Direct |
| 2025-10-17 | Class A Common Stock | F | 2072 | $3.08 | Disposed | 971878 | Direct |
| 2025-10-17 | Class A Common Stock | M | 7833 | $0.75 | Acquired | 979711 | Direct |
| 2025-10-17 | Class A Common Stock | F | 4774 | $3.08 | Disposed | 974937 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-17 | Stock Option (Right to Buy) | $0.75 | M | 3400 | Disposed | 2025-10-22 | Class A Common Stock (3400) | Direct |
| 2025-10-17 | Stock Option (Right to Buy) | $0.75 | M | 7833 | Disposed | 2025-10-22 | Class A Common Stock (7833) | Direct |
Footnotes
F1: Represents a "net exercise" of outstanding stock options. The reporting person received 1,328 shares of common stock on net exercise of option to purchase 3,400 shares of common stock. The Company withheld 2,072 shares of common stock underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on October 17, 2025 of $3.08, pursuant to the terms of the 2010 Stock Option and Grant Plan.
F2: Represents a "net exercise" of outstanding stock options. The reporting person received 3,059 shares of common stock on net exercise of option to purchase 7,833 shares of common stock. The Company withheld 4,774 shares of common stock underlying the option for payment of the exercise price and tax withholdings, using the closing stock price on October 17, 2025 of $3.08, pursuant to the terms of the 2010 Stock Option and Grant Plan.
F3: The option is fully vested and exercisable.